Caribou Biosciences Inc

Caribou Biosciences’ CTO sells 6,228 shares at $1.93, a near‑market exit that hints at short‑term liquidity needs amid mixed insider sentiment and rising stock prices.

Caribou Biosciences insider buying by CTO Kelly Timothy signals executive confidence amid market volatility, offering a bullish sign while urging cautious evaluation of early‑stage biotech risks.

Insider buying surges at Caribou Biosciences, with executives buying 45k–700k shares/options, boosting sentiment and signaling future upside for the biotech firm.